The human epithelial cell cytotoxicity assay for determining tissue specific toxicity

Area of Science:

• Toxicology
• Cell Biology
• Drug Development

Background:

• Assessing organ-specific cytotoxicity is crucial for evaluating potential risks of various chemical agents.
• Existing methods may not fully capture the nuanced responses of different human epithelial tissues.
• The Human Epithelial Cell Cytotoxicity (HECC) assay was developed to address these limitations.

Purpose of the Study:

• To describe the methodology and application of the HECC assay for determining organ-specific cytotoxicity.
• To highlight the versatility of the HECC assay for evaluating diverse agents, including drugs and environmental chemicals.
• To establish a framework for comparing the relative sensitivity of different human epithelial cell lines to toxic agents.

Main Methods:

• Utilizes early-passage human epithelial cells from eight distinct tissue types (skin, mammary, prostate, renal, bronchial, oral, ecto-cervix, liver).
• Exposes cells to multiple concentrations of test agents over a three-day period.
• Evaluates inhibition of growth, mitochondrial function, and specific biomarkers (PCNA, albumin synthesis) to determine the toxic concentration 50% (TC(50)).

Main Results:

• The HECC assay provides organ-specific cytotoxicity data by comparing TC(50) values across different epithelial cell lines.
• It allows for the determination of relative sensitivity of each epithelial cell type to a given test agent.
• Preliminary assays establish appropriate concentration ranges for accurate testing.

Conclusions:

• The HECC assay is a valuable tool for assessing the organ-specific toxicity of a wide range of chemical substances.
• It enables a comparative analysis of tissue sensitivity, crucial for risk assessment.
• The assay supports the safety evaluation of pharmaceuticals, personal care products, and environmental toxicants.